ahlam1399
03-28-2016, 08:42 PM
Shire gets favorable ruling against Allergan in Lialda patent case
March 28 (Reuters) - A U.S. district court on Monday ruled in favor of Shire Plc, preventing Allergan Plc from selling generic versions of Lialda, the ulcerative colitis drug, in the United States until 2020.
http://rc.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/rc/1/rc.img (http://rc.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/rc/1/rc.htm)
http://rc.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/rc/2/rc.img (http://rc.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/rc/2/rc.htm)
http://rc.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/rc/3/rc.img (http://rc.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/rc/3/rc.htm)
http://da.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/a2.img (http://da.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/a2.htm)
http://adchoice.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/ach.img (http://adchoice.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/ach.htm)http://pi.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/a2t.imghttp://pi2.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e8f0473/sc/7/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=MEdjODQwDzs:7Ix5GDLxgs4:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=MEdjODQwDzs:7Ix5GDLxgs4:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=MEdjODQwDzs:7Ix5GDLxgs4:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=MEdjODQwDzs:7Ix5GDLxgs4:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=MEdjODQwDzs:7Ix5GDLxgs4:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/MEdjODQwDzs
March 28 (Reuters) - A U.S. district court on Monday ruled in favor of Shire Plc, preventing Allergan Plc from selling generic versions of Lialda, the ulcerative colitis drug, in the United States until 2020.
http://rc.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/rc/1/rc.img (http://rc.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/rc/1/rc.htm)
http://rc.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/rc/2/rc.img (http://rc.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/rc/2/rc.htm)
http://rc.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/rc/3/rc.img (http://rc.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/rc/3/rc.htm)
http://da.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/a2.img (http://da.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/a2.htm)
http://adchoice.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/ach.img (http://adchoice.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/ach.htm)http://pi.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/a2t.imghttp://pi2.feedsportal.com/r/247396075449/u/49/f/654213/c/35217/s/4e8f0473/sc/7/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e8f0473/sc/7/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=MEdjODQwDzs:7Ix5GDLxgs4:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=MEdjODQwDzs:7Ix5GDLxgs4:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=MEdjODQwDzs:7Ix5GDLxgs4:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=MEdjODQwDzs:7Ix5GDLxgs4:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=MEdjODQwDzs:7Ix5GDLxgs4:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/MEdjODQwDzs